VEROVACCiNES

Curated by Signal

Developer of animal vaccines to treat infectious diseases

Overview

Developer of animal vaccines to treat infectious diseases. The company develops novel vaccines based on recombinant strains of the yeast Kluyveromyces lactis, which express one or more antigens for the treatment of infectious diseases of animals.

Key facts

Founded: 2017
Headquarters: Halle, Germany
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

ANIMA RES
Online platform offering 3D medical animations to provide medical education
Health TechnologyBonn, Germany
Fit-Q
Digital workout creator app for proffesionals
Health TechnologyHagenow, Germany
Everchange
Digital health platform offering information related to women health
Health TechnologyHamburg, Germany

About VEROVACCiNES

What does VEROVACCiNES do?

Developer of animal vaccines to treat infectious diseases.

Where is VEROVACCiNES headquartered?

VEROVACCiNES is headquartered in Halle, Germany.

When was VEROVACCiNES founded?

VEROVACCiNES was founded in 2017.

Which sector is VEROVACCiNES in?

VEROVACCiNES operates in Health Technology.

Who are VEROVACCiNES's competitors?

Companies similar to VEROVACCiNES include ANIMA RES, Fit-Q, and Everchange.